focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

Share Price Information for Tissue Regenix Group (TRX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 61.50
Bid: 61.00
Ask: 62.00
Change: 0.00 (0.00%)
Spread: 1.00 (1.639%)
Open: 61.50
High: 61.50
Low: 61.50
Prev. Close: 61.50
TRX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 2.10 Announcement

3 Apr 2007 14:28

Torex Retail PLC03 April 2007 Torex Retail PLC 3 April 2007 Torex Retail PLC ("Torex" or "the Group") Disclosure in accordance with Rule 2.10 of the City Code This announcement is being made further to that issued by Torex on 30 March 2007relating to its appointment of Jefferies International Limited to advise it on arange of strategic options including the possible sale of the Group. In accordance with Rule 2.10 of the City Code on Takeovers and Mergers, Torexconfirms that it has the following relevant securities in issue: - 414,825,509 ordinary shares of 1 pence each under the ISIN code GB 0034291632 - 5.5% sterling denominated convertible bonds due 2011 amounting to £65 million, which are convertible into fully paid preference shares in the capital of Torex Retail (Jersey) Limited and are then exchangeable into up to 75,581,395 fully paid ordinary shares of Torex (based on the initial exchange price of £0.86 pence per ordinary share) under the ISIN code XS 0259948254 ENQUIRIES College Hill Tel: 020 7457 2020 Carl Franklin Mark Garraway Dealing Disclosure Requirements Under the provisions of Rule 8.3 of the Takeover Code (the "Code"), if anyperson is, or becomes, "interested" (directly or indirectly) in 1% or more ofany class of "relevant securities" of Torex, all "dealings" in any "relevantsecurities" of that company (including by means of an option in respect of, or aderivative referenced to, any such "relevant securities") must be publiclydisclosed by no later than 3.30 pm (London time) on the London business dayfollowing the date of the relevant transaction. This requirement will continueuntil the date on which the offer becomes, or is declared, unconditional as toacceptances, lapses or is otherwise withdrawn or on which the "offer period"otherwise ends. If two or more persons act together pursuant to an agreement orunderstanding, whether formal or informal, to acquire an "interest" in "relevantsecurities" of Torex, they will be deemed to be a single person for the purposeof Rule 8.3. Under the provisions of Rule 8.1 of the Code, all "dealings" in "relevantsecurities" of Torex by Torex or by any of their respective "associates", mustbe disclosed by no later than 12.00 noon (London time) on the London businessday following the date of the relevant transaction. A disclosure table, giving details of the companies in whose "relevantsecurities" "dealings" should be disclosed, and the number of such securities inissue, can be found on the Takeover Panel's website atwww.thetakeoverpanel.org.uk. "Interests in securities" arise, in summary, when a person has long economicexposure, whether conditional or absolute, to changes in the price ofsecurities. In particular, a person will be treated as having an "interest" byvirtue of the ownership or control of securities, or by virtue of any option inrespect of, or derivative referenced to, securities. Terms in quotation marks are defined in the Code, which can also be found on thePanel's website. If you are in any doubt as to whether or not you are requiredto disclose a "dealing" under Rule 8, you should consult the Panel. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
23rd Nov 20105:18 pmRNSIssue of Equity
20th Oct 20107:00 amRNSHalf Yearly Report
18th Aug 20102:19 pmRNSHolding(s) in Company
10th Aug 20107:00 amRNSCE Mark Grant
5th Aug 20103:43 pmRNSPatents approved
1st Jul 201010:38 amRNSHolding(s) in Company
29th Jun 20104:37 pmRNSIssue of Equity
29th Jun 20108:06 amRNSFirst day dealings in Tissue Regenix
29th Jun 20107:00 amRNSFirst Day of Dealings
28th Jun 20102:20 pmRNSResult of General Meeting
10th Jun 20103:39 pmRNSSch 1 - Oxeco (to be renamed Tissue Regenix Group)
3rd Jun 20107:00 amRNSAcquisition
21st Apr 201011:20 amRNSResult of AGM
26th Mar 20107:00 amRNSFinal Results
11th Jan 20105:05 pmRNSHolding(s) in Company
23rd Dec 20091:49 pmRNSHolding(s) in Company
23rd Dec 200912:07 pmRNSHolding(s) in Company
22nd Dec 20094:33 pmRNSHolding(s) in Company
17th Dec 20093:50 pmRNSHolding(s) in Company
17th Dec 20092:47 pmRNSHolding(s) in Company
9th Dec 20099:28 amRNSInvesting Policy
23rd Oct 20097:00 amRNSInterim financial report
25th Aug 20092:30 pmRNSHolding(s) in Company
23rd Jul 20097:00 amRNSClosure of subsidiary business
2nd Jun 200912:00 pmRNSAppointment of Non-Executive Director
26th May 20093:00 pmRNSChange of Nominated Adviser Name
20th Apr 20097:00 amRNSFinal Results
24th Mar 200910:18 amRNSAppointment of Broker
18th Mar 200911:54 amRNSStrategic Review and Directorate Change
19th Nov 20087:00 amRNSDirectorate Change
16th Oct 20087:00 amRNSInterim Results
9th Jul 200812:39 pmRNSHolding(s) in Company
29th May 200812:10 pmRNSAGM Statement
30th Apr 20085:27 pmRNSAudited Final Results
28th Sep 20077:04 amRNSInterim Results
17th Aug 20077:01 amRNSAIM Rule 26 Website
29th Jun 20079:00 amRNSTotal Voting Rights
29th Jun 20078:00 amRNSAccounts to 31 January 2007
29th Jun 20078:00 amRNSAppointment of Directors
25th Jun 20071:38 pmRNSEGM Statement
20th Jun 20077:01 amRNSDisposal & Administration
14th Jun 20074:23 pmRNSRule 8.3- Torex Retail-Amend
13th Jun 20075:34 pmRNSRule 8.3-Torex Retail CB 5.5%
7th Jun 20072:11 pmRNSNotice of EGM
1st Jun 20077:01 amRNSBoard change
17th May 20073:58 pmRNSReview of strategic options
13th Apr 20073:33 pmRNSRule 8.3- Torex Retail Plc
3rd Apr 20072:28 pmRNSRule 2.10 Announcement
30th Mar 20075:03 pmRNSStrategic Review
27th Mar 20075:20 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.